An Observational Study to Assess Effectiveness and Safety of The R21/Matrix-M Malaria Vaccine

RecruitingOBSERVATIONAL
Enrollment

2,308

Participants

Timeline

Start Date

June 16, 2025

Primary Completion Date

October 30, 2026

Study Completion Date

December 31, 2026

Conditions
Malaria,FalciparumMorality
Interventions
OTHER

Case control study of clinical malaria

Case control study of clinical malaria

OTHER

Case control study of severe malaria

Case control study of severe malaria

OTHER

Case control study of death (all cause)

Case control study of death (all cause)

Trial Locations (5)

Unknown

RECRUITING

Unité de Recherche Clinique de Nanoro (URCN), Institut de Recherche en Sciences de la Santé, Direction Régionale du Centre-Ouest (IRSS-DRCO), Bousse, Boussé

RECRUITING

Centre de Recherche et de Lutte contre le Paludisme Institut National de Santé Publique, boulevard Nangui Abrogoua près État Major des Armées, Toumodi

RECRUITING

University of Ilorin Department of Pediatrics University of Ilorin Teaching Hospital, Ilorin, Nigeria, Yenagoa

RECRUITING

Infectious Diseases Research Collaboration (IDRC), Uganda, Busia

RECRUITING

Makerere University College of Health Sciences, Mukono

All Listed Sponsors
lead

Serum Institute of India Pvt. Ltd.

INDUSTRY

NCT07009847 - An Observational Study to Assess Effectiveness and Safety of The R21/Matrix-M Malaria Vaccine | Biotech Hunter | Biotech Hunter